CIK 0001281895
- Non-accelerated filer
- Smaller reporting company
ROCKET PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RCKT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 646-440-9100
- Business address
- 350 FIFTH AVENUE, SUITE 7530, NEW YORK, NY, 10118
- Former names
- INOTEK PHARMACEUTICALS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $417,906
- in 7 filings
Net −$417,906. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-02-14 | Garcia-Parada Carlos Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +54,006 | 54,006 | ||
| 2022-02-14 | Garcia-Parada Carlos Chief Financial Officer | Grant or award · Restricted Stock Units | +17,322 | 17,322 | ||
| 2021-09-13 | Garcia-Parada Carlos Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-01-04 | Garcia-Parada Carlos Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 |
Page 1 of 1 · 4 trades